Business Wire - Teva Reports Third Quarter 2007 Results
Tuesday, December 16th, 2008 The world’s largest generics company is also expected to be strong in biogenerics. In 2004, Teva purchased Sicor, which markets G-CSF, human growth hormone and interferon alpha in Eastern Europe and emerging markets. Gate, a subsidiary of Teva, sells human growth hormone in the United States as branded Tev-Tropin.
In 2005, Teva acquired Ivax, which is developing generic insulin and human grow…
